Perioperative management of the patient with cancer

被引:13
作者
Lefor, AT
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Div Surg Oncol, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA
关键词
D O I
10.1378/chest.115.suppl_2.165S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
There are a number of conditions that present commonly in patients with cancer that may have a significant effect on the preoperative, intraoperative, and postoperative treatment of these patients. These effects can be broadly categorized into anatomic and physiologic effects and may be examined as direct effects of the tumor or as effects of therapy administered for the tumors, Tumors that cause anatomic effects of importance to perioperative management include head and neck tumors with airway obstruction, mediastinal masses with respiratory compromise, pericardial effusion and cardiac tamponade, and superior vena cava syndrome. Some tumors that cause physiologic effects include pheochromocytomas and carcinoid tumors. Anatomic effects of tumor therapy are important after radiation therapy to the head and neck and after radiation therapy to the abdomen, Tumor therapy has important physiologic effects in such areas as the cardiopulmonary complications of chemotherapy, hematologic effects of chemotherapy, steroid administration, and wound healing. While the list of topics is not exhaustive, this is a useful framework for discussing the effects of tumors and their therapy on the cancer patient, especially in regard to perioperative management. Most importantly, these examples demonstrate the importance of close cooperation among surgeon, anesthesiologist, and referring physician to assure the conduct of surgical procedures on the patient with cancer with maximal safety.
引用
收藏
页码:165S / 171S
页数:7
相关论文
共 28 条
[1]   CISPLATIN (P), BLEOMYCIN (B), AND METHOTREXATE (M) PREOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED VULVAR CARCINOMA [J].
BENEDETTIPANICI, P ;
GREGGI, S ;
SCAMBIA, G ;
SALERNO, G ;
MANCUSO, S .
GYNECOLOGIC ONCOLOGY, 1993, 50 (01) :49-53
[2]  
BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865
[3]   EXPERIMENTAL AND CLINICAL OBSERVATIONS OF THE EFFECTS OF CYTO-TOXIC CHEMOTHERAPEUTIC DRUGS ON WOUND-HEALING [J].
BLAND, KI ;
PALIN, WE ;
VONFRAUNHOFER, JA ;
MORRIS, RR ;
ADCOCK, RA ;
TOBIN, GR .
ANNALS OF SURGERY, 1984, 199 (06) :782-790
[4]  
CASTHELY PA, 1986, ANESTH ANALG, V65, P809
[5]  
CHEN P, 1996, SURG PROBLEMS AFFECT, P143
[6]   HORMONAL RESPONSES TO GRADED SURGICAL STRESS [J].
CHERNOW, B ;
ALEXANDER, HR ;
SMALLRIDGE, RC ;
THOMPSON, WR ;
COOK, D ;
BEARDSLEY, D ;
FINK, MP ;
LAKE, CR ;
FLETCHER, JR .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) :1273-1278
[7]  
COHN I, 1968, SURG GYNECOL OBSTETR, V127, P1201
[8]  
Heyman MR, 1996, SURG PROBLEMS AFFECT, P373
[9]   RATIONAL APPROACH TO DOSAGE AND PREPARATION OF PARENTERAL GLUCOCORTICOID SUBSTITUTION THERAPY DURING SURGICAL PROCEDURES - SHORT REVIEW [J].
KEHLET, H .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1975, 19 (04) :260-264
[10]   PULMONARY TOXICITY OF ANTI-NEOPLASTIC AGENTS - ANESTHETIC AND POSTOPERATIVE IMPLICATIONS [J].
KLEIN, DS ;
WILDS, PR .
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1983, 30 (04) :399-405